| Literature DB >> 20137066 |
Elke Peeters1, Andrea Sass, Eshwar Mahenthiralingam, Hans Nelis, Tom Coenye.
Abstract
BACKGROUND: Burkholderia cepacia complex bacteria are opportunistic pathogens, which can cause severe respiratory tract infections in patients with cystic fibrosis (CF). As treatment of infected CF patients is problematic, multiple preventive measures are taken to reduce the infection risk. Besides a stringent segregation policy to prevent patient-to-patient transmission, clinicians also advise patients to clean and disinfect their respiratory equipment on a regular basis. However, problems regarding the efficacy of several disinfection procedures for the removal and/or killing of B. cepacia complex bacteria have been reported. In order to unravel the molecular mechanisms involved in the resistance of biofilm-grown Burkholderia cenocepacia cells against high concentrations of reactive oxygen species (ROS), the present study focussed on the transcriptional response in sessile B. cenocepacia J2315 cells following exposure to high levels of H2O2 or NaOCl.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20137066 PMCID: PMC2830190 DOI: 10.1186/1471-2164-11-90
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Figure 1Effect of treatments with HOor NaOCl on the number of viable sessile . The average relative fluorescence signals (%) show the fraction of viable B. cenocepacia J2315 sessile cells in untreated biofilms and in biofilms treated with H2O2 (0.3%, 30 min; dark grey bars) or NaOCl (0.02%, 5 min; pale grey bars). Error bars represent standard deviations.
Overview of the number (fraction) of probes for which a significant up- or downregulation was observed in response to treatments with H2O2 or NaOCl.
| NaOCl (0.02%, 5 min) | ||
|---|---|---|
| CDS (n = 7153) | 315 (4.4%) | 386 (5.4%) |
| IG (n = 1520) | 39 (2.6%) | 56 (3.7%) |
| tRNA (n = 47) | 20 (42.6%) | 8 (17.0%) |
| rRNA (n = 9) | 9 (66.7%) | 1 (11.1%) |
| CDS (n = 7153) | 185 (2.6%) | 331 (4.6%) |
| IG (n = 1520) | 54 (3.6%) | 68 (4.5%) |
| tRNA (n = 47) | 0 (0%) | 3 (6.4%) |
| rRNA (n = 9) | 0 (0%) | 0 (0%) |
The number of probes on the array that correspond to B. cenocepacia J2315 protein encoding sequences (CDS), intergenic regions (IGs) and tRNA- or rRNA-encoding sequences are shown for each category (n).
List of genes involved in the (oxidative) stress response of sessile B. cenocepacia J2315 cells exposed to H2O2 or NaOCl.
| Fold change in expression in treated biofilms vs untreated biofilms | ||||||
|---|---|---|---|---|---|---|
| BCAS0085 | Organic hydroperoxide resistance protein | 49.3 | 1438.4 | 1307.0 | 560.7 | 20.3 |
| BCAM1217 | Alkyl hydroperoxide reductase C subunit ( | 41.3 | 68.7 | 46.7 | 20.4 | 15.0 |
| BCAL0771 | Non-heme chloroperoxidase | 37.7 | 27.0 | 65.8 | 97.5 | NS |
| BCAM0896 | Organic hydroperoxide resistance protein | 36.5 | 27.6 | 23.2 | 15.1 | 37.2 |
| BCAL1766 | OsmC-like protein (Ohr protein, see text) | 18.0 | 28.2 | 43.8 | 36.9 | 75.2 |
| BCAM1216 | Alkyl hydroperoxide reductase F subunit ( | 15.5 | 182.5 | 122.5 | 49.5 | 2.1 |
| BCAM0931 | Catalase precursor | 5.7 | 98.8 | 32.3 | 6.1 | NS |
| BCAL1106 | Cytochrome b561 family protein | 4.1 | 1.7 | 12.7 | 42.5 | 8.3 |
| BCAL2780 | Putative thioredoxin protein | 2.9 | 1.9 | 3.1 | 3.3 | NS |
| BCAL3035 | Thioredoxin reductase ( | 2.8 | - | - | - | NS |
| BCAM0930 | Putative ankyrin-like protein ( | 2.7 | - | - | - | NS |
| BCAL3477 | Putative catalase | 2.7 | 1.7 | 6.5 | 23.1 | NS |
| BCAL2014 | Carboxymuconolactone decarboxylase family | 2.7 | 2.3 | 2.1 | 1.7 | 3.3 |
| BCAL1761 | MarR family regulatory protein ( | 2.4 | - | - | - | NS |
| BCAL2013 | AhpC/TSA family protein | 2.1 | - | - | - | NS |
| BCAL1900 | Thioredoxin A ( | 2.0 | - | - | - | 2.1 |
| BCAL3299 | Catalase ( | 1.8 | 1.4 | 1.7 | NS | NS |
| BCAM2107 | Catalase ( | NS | NS | NS | NS | NS |
| BCAL3214 | Carboxymuconolactone decarboxylase family | NS | - | - | - | 35.1 |
| BCAL0953 | Putative recombinase A ( | 2.6 | NS | 1.8 | NS | 1.9 |
| BCAL3297 | DNA-binding protein ( | NS | - | - | - | NS |
| BCAM0961 | Aconitase A ( | NS | - | - | - | NS |
| BCAM1833 | Aconitase B ( | 5.1 | 2.7 | 3.5 | 3.1 | 2.1 |
| BCAL2192 | Conserved hypothetical protein ( | 2.4 | - | - | - | 2.4 |
| BCAL2193 | Ferredoxin ( | 2.5 | - | - | - | 2.5 |
| BCAL2194 | Chaperone protein HscA homologue ( | 2.4 | - | - | - | 2.4 |
| BCAL2195 | Chaperone protein HscB homologue ( | 2.3 | - | - | - | 2.3 |
| BCAL2196 | Iron-sulfur cluster assembly protein ( | 1.6 | - | - | - | 1.6 |
| BCAL2197 | Iron-sulfur cluster scaffold protein ( | 3.4 | - | - | - | 3.4 |
| BCAL2198 | Cysteine desulfurase ( | 2.9 | - | - | - | 2.9 |
| BCAL2199 | Transcriptional regulator ( | 2.3 | - | - | - | 2.3 |
| BCAL0787 | RNA polymerase σ32 factor | 4.7 | 2.3 | 2.7 | 2.5 | 2.6 |
| BCAL1369 | Putative RNA polymerase σ70 factor ( | 2.2 | - | - | - | NS |
| BCAL1688 | Putative RNA polymerase σ70 factor ( | 6.4 | 5.7 | 5.9 | 12.9 | NS |
| BCAL3478 | Putative RNA polymerase σ factor | 3.4 | NS | 5.5 | 16.6 | NS |
The results represent the fold change in gene expression in the treated biofilms compared to the gene expression in the untreated biofilms. -: no qPCR experiments were performed. NS: no significant change in expression was observed between the treated and the untreated biofilms (p > 0.05).
Figure 2Putative OxyR-binding sites upstream of BCAL2297, BCAL3299 (. The four tetranucleotide sequences in the E. coli OxyR-binding consensus sequence are underlined and the nucleotides matching the consensus sequence are indicated by grey shading [74].
Figure 3Effect of treatment with HOon the number of viable sessile . The average relative fluorescence signals (%) show the fraction of viable sessile cells in untreated biofilms and in biofilms treated with H2O2 (0.3%) for 15, 30 or 60 min. Data were obtained for biofilms of B. cenocepacia J2315 (black bars), C5424 (dark grey bars), MDL1 (katA mutant; pale grey bars) and MDL2 (katB mutant; white bars). Error bars represent standard deviations.
Clusters of adjacent genes that show similar changes in expression when B. cenocepacia J2315 biofilms are exposed to H2O2 or NaOCl.
| Fold change in expression in treated biofilms vs untreated biofilms | |||
|---|---|---|---|
| BCAL1763 | Putative exported protein | 15.5 | 30.2 |
| BCAL1764 | Putative exported protein | 5.3 | 15.3 |
| BCAL1765 | Putative exported protein | 7.5 | 31.0 |
| BCAL1766 | OsmC-like protein (Ohr protein, see text) | 18.0 | 75.2 |
| BCAS0084 | TetR family regulatory protein | 5.9 | 3.8 |
| BCAS0085 | Organic hydroperoxide resistance protein | 49.3 | 20.3 |
| BCAS0086 | Putative exported lipase | 96.6 | 11.3 |
| BCAM0930 | Putative ankyrin-like protein ( | 2.7 | NS |
| BCAM0931 | Catalase precursor | 5.7 | NS |
| BCAM1216 | Alkyl hydroperoxide reductase F subunit ( | 15.5 | 2.1 |
| BCAM1217 | Alkyl hydroperoxide reductase C subunit ( | 41.3 | 15.0 |
| BCAL1688 | Putative RNA polymerase σ 70 factor ( | 6.4 | NS |
| IG1_1847123 | IG between BCAL1688 and BCAL1689 | 2.9 | NS |
| BCAL1689 | Mbt-like protein ( | 3.8 | NS |
| BCAL1690 | Dioxygenase ( | 2.3 | NS |
| BCAL2192 | Conserved hypothetical protein ( | 2.4 | NS |
| BCAL2193 | Ferredoxin ( | 2.5 | NS |
| BCAL2194 | Chaperone protein HscA homologue ( | 2.4 | NS |
| BCAL2195 | Chaperone protein HscB homologue ( | 2.3 | NS |
| BCAL2196 | Iron-sulfur cluster assembly protein ( | 1.6 | NS |
| BCAL2197 | Iron-sulfur cluster scaffold protein ( | 3.4 | NS |
| BCAL2198 | Cysteine desulfurase ( | 2.9 | NS |
| BCAL2199 | Transcriptional regulator protein ( | 2.3 | NS |
| BCAL1105 | Exported protein | 6.8 | 12.7 |
| BCAL1106 | Cytochrome b561 family protein | 4.1 | 8.3 |
| BCAL1107 | Oxidoreductase | 2.7 | 3.4 |
| BCAL3477 | Putative catalase | 2.7 | NS |
| BCAL3478 | Putative RNA polymerase σ factor | 3.4 | NS |
The results represent the fold change in gene expression in the treated biofilms compared to the gene expression in the untreated biofilms (based on the microarray analysis). NS: no significant change in expression was observed between the treated and the untreated biofilms (p > 0.05).
Figure 4The protein encoded by BCAL1766 belongs to the Ohr family. Amino acid sequences of three upregulated Ohr proteins in B. cenocepacia J2315 (encoded by BCAS0085, BCAM0896 and BCAL1766) and of P. aeruginosa PAO1 Ohr (OhrPAO1) and OsmC (OsmCPAO1) and E. coli K-12 MG1655 OsmC (OsmCK12) were aligned using the CLUSTAL W program using standard settings [75]. The regions of black shading and white lettering show the conserved regions found in either the Ohr homologues or the OsmC homologues. Grey shading indicates that identical amino acid sequences are found in both Ohr and OsmC homologues. The triangles point to the highly conserved C residues in both families.
Figure 5Increased lipase activity in the supernatant of HO-treated . Lipase activity was determined in the supernatant of B. cenocepacia J2315 biofilms that were either untreated (diamonds) or that were treated with 0.3% H2O2 for 15 (rectangles), 30 (triangles) or 60 min (circles). The graph shows a representative example of the obtained curves using 4-MU oleate as fluorogenic substrate. Signals are expressed as normalized fluorescence units (RFU). Error bars represent standard deviations.
Figure 6Effect of treatments with HOon the expression of the IGs IG1_2935724 and IG1_3008003 and their adjacent genes. The expression of the genes BCAL2667 and BCAL2737 (grey bars) and BCAL2668 and BCAL2738 (black bars) and of the IGs (IG1_2935724 and IG1_3008003 [white bars]) in the treated biofilms is compared to the expression observed in the untreated biofilms. Error bars represent SEM. *: significant upregulation in treated biofilms compared to untreated biofilms (p < 0.05).
Figure 7Secondary structure of the putative 6S RNA in IG1_2935724 and the 6S RNA consensus structure. A. Secondary structure obtained for the intergenic region spanning nucleotides 2935805 to 2935985 (B. cenocepacia J2315; chromosome 1) as predicted by mfold using standard settings [76]. B. Secondary structure of the 6S RNA consensus structure (RFAM database [53]).
Genes of the BcepMu prophage that have an increased expression in H2O2 exposed B. cenocepacia J2315 biofilms (30 min).
| Gene | BcepMu gene assignments | Annotation | |
|---|---|---|---|
| IG3_584892 | IG upstream of BCAS0540 | 8.5 | |
| BCAS0540 | BcepMu16 | Hypothetical protein | 10.0 |
| BCAS0540A | BcepMu15 | Hypothetical protein | 9.3 |
| BCAS0540B | BcepMu14 | Hypothetical protein | No probe present on array |
| BCAS0541 | No BcepMu assignment | Hypothetical protein | 9.6 |
| IG3_601361 | IG between BcepMu14 and BcepMu13 | 12.8 | |
| BCAS0542 | BcepMu13 | Hypothetical protein | 7.7 |
| BCAS0543 | BcepMu12 | Putative phage transcriptional regulator | 10.1 |
| BCAS0544 | BcepMu11 | Hypothetical protein | 8.3 |
| BCAS0545 | BcepMu10 | Hypothetical protein | 1.7 |
| BCAS0546 | BcepMu9 | Tn552/IS1604 rve transposase | 2.6 |
| BCAS0547 | BcepMu8 | Putative DNA-binding phage protein | 3.8 |
| BCAS0548 | BcepMu7 | Hypothetical protein | 3.9 |
| BCAS0549 | BcepMu6 | Hypothetical protein | 3.7 |
| IG3_607288 | IG between BcepMu5 and BcepMu6 | 4.0 | |
| BCAS0550 | BcepMu5 | Hypothetical protein | 3.7 |
| BCAS0551 | BcepMu4 | Hypothetical protein | No probe present on array |
| IG3_608364 | IG between BcepMu3 and BcepMu4 | 2.7 | |
| BCAS0552 | BcepMu3 | Single-stranded DNA binding protein | 2.1 |
| BCAS0553 | BcepMu2 | Mu gp16 gemA | 1.7 |
| BCAS0554 | BcepMu1 | Mu protein C/Mor gp17 transcription regulator | 1.9 |
The results represent the fold change in expression in the treated biofilms compared to the expression in the untreated biofilms (based on the microarray analysis).
Figure 8Effect of treatments with HOon the expression of three selected BcepMu prophage genes. The expression of BCAS0543 (BcepMu12; grey bars), BCAS0546 (BcepMu9; white bars) and BCAS0547 (BcepMu8; black bars) in the H2O2-treated biofilms is compared with the expression observed in the untreated biofilms. Error bars represent SEM. *: significant upregulation in treated biofilms compared to untreated biofilms (p < 0.05).
Strains used in the present study.
| Strain | LMG number | Strain information | Reference |
|---|---|---|---|
| LMG 16656 | ET12 strain, CF patient, UK | [ | |
| LMG 18827 | Epidemic strain, CF patient, Canada | [ | |
| - | C5424 | [ | |
| - | C5424 | [ | |
| LMG 17588 | Soil, USA | [ | |
| LMG 24507 | PHDC strain, soil, USA | [ | |
| LMG 24506 | PHDC strain, CF patient, USA | [ | |
| LMG 19182 | Pea rhizosphere, USA | [ | |
| LMG 24508 | Epidemic strain, CF patient, USA | [ |